Curasight is active in the pharmaceutical industry. The company specializes in research and development of various drug candidates. The product portfolio includes, for example, research and development within Positron Emission Tomography (PET) and related ancillary services. The business is operating with the largest presence within Scandinavia. Curasight is headquartered in Copenhagen.

Quotes for Curasight A/S

Right Now

+/-
-0.6
%
-1,94%
Latest
30.3
High
31
Low
29.25
Volume
24 673
Turnover (DKK)
739 233
Value (MDKK)
518,9

Board

CEO

  • Ulrich Krasilnikoff

Chairman Of The Board

  • Per Falholt

Board

  • Andreas Kjær
  • Charlotte Vedel
  • Lars Trolle
  • Ulrich Krasilnikoff

Videos

Largest Owners

Name Capital % Votes % Date
Andreas Kjaer 35,13 35,13 2020-10-08
Ulrich Krasilnikoff 24,16 24,16 2020-10-08
Carsten Haagen Nielsen 14,03 14,03 2020-10-08
Jacob Madsen 5,27 5,27 2020-10-08
Lars Trolle 3,43 3,43 2020-10-08
Måns Flodberg 0,61 0,61 2020-10-08
Per Falholt 0,20 0,20 2020-10-08
Charlotte Vedel 0,04 0,04 2020-10-08
Holdings by Modular Finance AB. Compiled and processed data from various sources, including VP Securities, Morningstar and The Danish Financial Supervisory Authority (Finanstilsynet)

Upcoming reports

  • 2021-02-24 Bokslutskommuniké 2020

  • 2021-03-25 Årsstämma 2020

  • 2021-05-20 Delårsrapport 2021-Q1

  • 2021-08-24 Delårsrapport 2021-Q2